Over 3,000 Skin Cancer Patients Treated with the TOPEX System.............

DANBURY, Conn., May 11 /PR Newswire/ -- May is National Skin Cancer Awareness
month. TOPEX, Inc. located in Danbury, CT is helping to fight this disease
with a low energy or superficial x-ray therapy system designed specifically to
treat skin cancer as an alternative to surgery. Since first introduced in May
2007, over 3,000 patients were treated with the TOPEX system. As a standard of
care, the TOPEX system provides an alternative to surgery for treating basal
and squamous cell carcinomas, especially for those skin conditions requiring
difficult or extensive surgery in sensitive head and neck regions such as the
fold in the nose, eyelids, lips, corners of the mouth and the lining of the
ear that would otherwise lead to a poor cosmetic outcome. The TOPEX treatment
procedure does not require the use of anesthetics and eliminates the need for
skin grafting when surgery could result in a less than desirable cosmetic
outcome. This procedure is painless and benefits those patients who may have a
fear of surgery and needles, patients who have contraindications for
reconstructive surgery that are taking blood thinning medications and for
those that cannot tolerate general anesthesia.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090511/NY13868 )

TOPEX has a number of systems that treat skin cancer patients at Radiation
Oncology Departments, Medical Universities and Dermatology Practices in the
United States, Europe, South Africa and Australia.

Over 2.5M new skin cancer cases are diagnosed annually worldwide. This is
increasing at a rate of 4% per year. Increased exposure to the sun without
skin protection and a decreasing natural ozone layer are cited as the chief
causes of this increase - a problem estimated at over $3B in annual medical
treatment expenses. Over 80% of skin cancers occur in the head and neck
regions with 50% occurring in those over 60 years of age. The over 60
population is rising and is expected to double in size by 2025.

The clinical objective of TOPEX is to effectively treat skin cancer through
non-invasive therapeutic x-ray procedures with improved cosmetic outcomes.
With this objective, the TOPEX system provides advantages to patients,
physicians, healthcare providers and insurance payers that include the
following:

Patient - The procedure is accurate, safe, pain free and an alternative to
surgery.

Physician - Superficial x-ray therapy is a proven procedure for treating skin
cancer and has a lower potential for cosmetic issues combined with a high cure
rate history of effectiveness.

Practice - The TOPEX system is self-contained and has no special environmental
requirements such as special power sources, water hook-ups or waste disposal.
The compact mobile design requires minimal floor space and with mobility,
provides for greater patient treatment flexibility. The multi-position design
of the x-ray delivery system is ideal for treating wheel chair patients.

Payer - Superficial x-ray therapy provides an alternative to surgery and a
high cure rate history of effectiveness. The insurance industry, including
Medicare part B widely accepts this procedure for reimbursement.

TOPEX superficial x-ray therapy systems are manufactured in Danbury, CT. USA.

For additional information, visit the company website at www.topexmedical.com

SOURCE TOPEX, Inc.

John Brenna, President, TOPEX, Inc., +1-203-748-5918